AIT is then recommended in patients with moderate/severe AR and/or conjunctivitis who have a clinical history of symptoms despite use of symptom‐relieving medication and have a diagnosis of IgE‐mediated allergy.15 This evidence concerns the gene IGHE and conjunctivitis.